Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Head & Neck 1

Conditions

Head and Neck Neoplasms 1284Squamous Cell Carcinoma of Head and Neck 707Thyroid Neoplasms 297Carcinoma, Non-Small-Cell Lung 180Mouth Neoplasms 177Neoplasms 173Breast Neoplasms 172Lung Neoplasms 152Salivary Gland Neoplasms 143Oropharyngeal Neoplasms 132Nasopharyngeal Carcinoma 128Melanoma 117Carcinoma, Squamous Cell 116Colorectal Neoplasms 112Laryngeal Neoplasms 108Ovarian Neoplasms 102Esophageal Neoplasms 100Nasopharyngeal Neoplasms 96Prostatic Neoplasms 92Pancreatic Neoplasms 92Stomach Neoplasms 88Uterine Cervical Neoplasms 86Neoplasm Metastasis 86Thyroid Cancer, Papillary 78Carcinoma, Renal Cell 78Urinary Bladder Neoplasms 74Thyroid Nodule 68Sarcoma 65Colonic Neoplasms 63Small Cell Lung Carcinoma 62

Interventions

parathyroid hormone-related peptide (1-36) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Musculoskeletal Diseases × Head & Neck × Clear all
NCT00580788 2016-02-11

One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

University of Pittsburgh

Phase EARLY_PHASE1 Completed
14 enrolled 16 charts
Head & Neck

Humoral Hypercalcemia Of Malignancy, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡